Sodium butyrate, Histone deacetylase inhibitor
Be the first to review this product! Submit a review
|
(2 Publications)
- WB
Unknown
Western blot - Sodium butyrate, Histone deacetylase inhibitor (AB120948)
HeLa cells were incubated at 37°C for 6h with vehicle control (0 μM) and different concentrations of sodium butyrate (ab120948). Increased expression of histone H3 (acetyl K27) (ab4729) in HeLa cells correlates with an increase sodium butyrate concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab4729 at 1 μg/ml and ab8227 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.
All lanes:
Western blot - Anti-Histone H3 (acetyl K27) antibody - ChIP Grade (<a href='/en-us/products/primary-antibodies/histone-h3-acetyl-k27-antibody-chip-grade-ab4729'>ab4729</a>)
Predicted band size: 15 kDa
Observed band size: 17 kDa
true
Exposure time: 10s
- Chemical Structure
Lab
Chemical Structure - Sodium butyrate, Histone deacetylase inhibitor (AB120948)
2D chemical structure image of ab120948, Sodium butyrate, Histone deacetylase inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 43:114406 PubMed38963759
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 233:3578-3589 PubMed29044512
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com